Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Intuitive Surgical (ISRG - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Intuitive Surgical is a member of the Medical sector. This group includes 840 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ISRG is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ISRG's full-year earnings has moved 2.25% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, ISRG has returned 26.01% so far this year. At the same time, Medical stocks have lost an average of 5.81%. As we can see, Intuitive Surgical is performing better than its sector in the calendar year.
To break things down more, ISRG belongs to the Medical - Instruments industry, a group that includes 93 individual companies and currently sits at #63 in the Zacks Industry Rank. This group has gained an average of 4.17% so far this year, so ISRG is performing better in this area.
ISRG will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Intuitive Surgical (ISRG - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Intuitive Surgical is a member of the Medical sector. This group includes 840 individual stocks and currently holds a Zacks Sector Rank of #2. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ISRG is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ISRG's full-year earnings has moved 2.25% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, ISRG has returned 26.01% so far this year. At the same time, Medical stocks have lost an average of 5.81%. As we can see, Intuitive Surgical is performing better than its sector in the calendar year.
To break things down more, ISRG belongs to the Medical - Instruments industry, a group that includes 93 individual companies and currently sits at #63 in the Zacks Industry Rank. This group has gained an average of 4.17% so far this year, so ISRG is performing better in this area.
ISRG will likely be looking to continue its solid performance, so investors interested in Medical stocks should continue to pay close attention to the company.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ISRG - FREE